Actinium Pharmaceuticals (ATNM) Earnings Date, Estimates & Call Transcripts $1.86 -0.10 (-5.10%) (As of 09/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryLatest Earnings DateAug. 5EstimatedActual EPS (Aug. 5) -$0.38 Beat By $0.02 Consensus EPS (Aug. 5) -$0.40 Conference Call TranscriptConference Call Audio Get Actinium Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ATNM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueATNM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATNM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Actinium Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.42)$0.54$0.06Q2 20243($0.78)($0.38)($0.58)Q3 20243($0.77)($0.34)($0.49)Q4 20243($0.78)($0.27)($0.47)FY 202411($2.75)($0.45)($1.48)ATNM Earnings Date and InformationActinium Pharmaceuticals last issued its quarterly earnings results on August 5th, 2024. The reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.02. Actinium Pharmaceuticals has generated ($1.71) earnings per share over the last year (($1.71) diluted earnings per share). Earnings for Actinium Pharmaceuticals are expected to grow in the coming year, from ($1.38) to ($0.77) per share. Read More Actinium Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/5/2024Q2 2024($0.40)($0.38)+$0.02($0.38)-- 4/26/2024Q1 2024($0.42)($0.31)+$0.11($0.31)--3/29/2024Q4 2023($0.54)($0.33)+$0.21($0.33)-$0.08 million 11/2/2023Q3 2023-($0.49)($0.49)($0.49)-- 8/14/2023Q2 2023($0.50)($0.58)($0.08)($0.58)-- 5/15/2023Q1 2023($0.42)($0.43)($0.01)($0.43)-- Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/3/2023Q4 2022($0.41)($0.42)($0.01)($0.42)$5.17 million- 11/14/2022Q3 2022($0.30)($0.38)($0.08)($0.38)$2.90 million$0.05 million11/14/2022Q3 2022($0.30)($0.38)($0.08)($0.38)$2.90 million$0.05 million 8/12/2022Q2 2022($0.23)($0.33)($0.10)($0.33)$1.85 million$0.05 million8/12/2022Q2 2022($0.23)($0.33)($0.10)($0.33)$1.85 million$0.05 million 5/13/2022Q1 2022($0.31)($0.23)+$0.08($0.23)-$0.94 million5/13/2022Q1 2022($0.31)($0.23)+$0.08($0.23)-$0.94 million 11/12/2021Q3 2021($0.29)($0.30)($0.01)($0.30)$0.28 million$0.23 million11/12/2021Q3 2021($0.29)($0.30)($0.01)($0.30)$0.28 million$0.23 million 7/30/2021Q2 2021($0.30)($0.25)+$0.05($0.25)-$0.27 million7/30/2021Q2 2021($0.30)($0.25)+$0.05($0.25)-$0.27 million 5/14/2021Q1 2021($0.35)($0.29)+$0.06($0.29)-$0.62 million5/14/2021Q1 2021($0.35)($0.29)+$0.06($0.29)-$0.62 million 3/30/2021Q4($0.37)($0.37)----10/23/2020Q3 2020-($0.36)($0.36)($0.36)--10/23/2020Q3 2020-($0.36)($0.36)($0.36)--6/29/2020Q1($0.69)($0.90)($0.21)---11/12/2019Q3 2019($1.20)($1.20)-($1.20)--11/12/2019Q3 2019($1.20)($1.20)-($1.20)--11/12/2019Q3 2019($1.20)($1.20)-($1.20)--11/12/2019Q3 2019($1.20)($1.20)-($1.20)--11/12/2019Q3 2019($1.20)($1.20)-($1.20)--11/12/2019Q3 2019($0.04)($0.04)-($0.04)--11/12/2019Q3 2019($1.20)($1.20)-($0.04)-- Actinium Pharmaceuticals Earnings - Frequently Asked Questions When did Actinium Pharmaceuticals announce their last quarterly earnings? Actinium Pharmaceuticals (NYSE:ATNM) last announced its quarterly earning data on Monday, August 5, 2024. Learn more on ATNM's earnings history. Did Actinium Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Actinium Pharmaceuticals (NYSE:ATNM) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.02. Learn more on analysts' earnings estimate vs. ATNM's actual earnings. How can I listen to Actinium Pharmaceuticals's earnings conference call? The conference call for Actinium Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Actinium Pharmaceuticals's conference call transcript? The conference call transcript for Actinium Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Actinium Pharmaceuticals generate each year? Actinium Pharmaceuticals (NYSE:ATNM) has a recorded annual revenue of $81,000.00. How much profit does Actinium Pharmaceuticals generate each year? Actinium Pharmaceuticals (NYSE:ATNM) has a recorded net income of -$48.82 million. ATNM has generated -$1.71 earnings per share over the last four quarters. What is Actinium Pharmaceuticals's EPS forecast for next year? Actinium Pharmaceuticals's earnings are expected to grow from ($1.38) per share to ($0.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MGNX Earnings Results ZNTL Earnings Results INBX Earnings Results MRSN Earnings Results PYXS Earnings Results FULC Earnings Results CMPX Earnings Results XBIT Earnings Results PROC Earnings Results ATAI Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NYSE:ATNM) was last updated on 9/15/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredWhy billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most val...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
